Performance Sleep, Performance Dose 20 units (1mg Tesamorelin / 200mcg Ipamorelin) Frequency 5 days / week Administration Subcutaneous Timing PM, 60-90 minutes after last meal, close to bedtime Vial Size 12mg (10mg Tesamorelin / 2mg Ipamorelin) Reconstitution 2mL Bacteriostatic Water Cycle Length 3 months on, 2 months off Vials / Month 2 Vials / Cycle 6 Do not combine with other GH-stimulating peptides such as CJC-1295/Ipamorelin
In the body, they act as signaling molecules, influencing processes such as metabolism, hormone production, and cellular repair
Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval
" Les aclaramos muy bien a los pacientes que la mayora de los pptidos todava no fueron aprobados por la FDA , pero hablamos con ellos para que entiendan las necesidades de su salud y les damos acceso a pptidos que pueden ayudarlos a alcanzar sus objetivos", agrega
Ipamorelin can be used safely under medical supervision, and dangerously without it
